P38α MAP KINASE INHIBITORS: PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION

51-5

QUINAZOLINE BASED EGFR INHIBITORS: PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION

86-8

PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION OF ANTITUBULIN AGENTS

43-4

PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION OF ANTITUBULIN AGENTS

43-4

P38α MAP KINASE INHIBITORS: PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION

51-5

QUINAZOLINE BASED EGFR INHIBITORS: PHARMACOPHORE MODELING, 3D-QSAR, DOCKING AND DRUG LIKELINESS PREDICTION

86-8

239-246.qxd

Abstract: Various N, were synthesized by a three steps process. The structures of the synthesized compounds were confirmed by spectral data and elemental analyses. All the synthesized compounds were tested against two bacterial strains and two fungal strains. Bacterial strains included Gram positive Staphylococcus aureus and Gram negativeve Escherichia coli and fungal strains included Monascus purpurea and Penicillium citrinum. Most of the compounds showed moderate to good antibacterial as well as antifungal activity

Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancer

Suppl data</p